Jacob Waugh Net Worth & Insider Trades

Jacob Waugh - Chief Scientific Officer, Revance Therapeutics, Inc

As of May 21, 2015

What is Jacob Waugh's Net Worth?

The current estimated net worth of Revance Therapeutics, Inc's Chief Scientific Officer, Jacob Waugh, is estimated to be about $3.46M . Jacob Waugh owns about 25,000 units of Revance Therapeutics, Inc common stock. In the last year at Revance Therapeutics, Inc, Jacob Waugh has sold an estimated value of $2.72M worth.

What is Jacob Waugh's Past Insider Trading?

Jacob Waugh's largest purchase order was 69,380 units , worth over $538.39K on September 19, 2014. Jacob Waugh's largest sale order was 97,713 units , worth over $2.03M on September 19, 2014. In total, Jacob Waugh has made about 5 transactions over a year of their time at Revance Therapeutics, Inc. Jacob Waugh usually trades in May, with the busiest year in 2014.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jacob Waugh's' Mailing Address?

  • Mailing address is 7555 Gateway Boulevard Newark CA 94560 CA

Revance Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark J. Foley 2020 $650,000 - $7,794,350 - $328,331 $8,255 $8,780,936
Mark J. Foley 2019 $189,764 $150,000 $11,728,370 $5,112,573 - $9,723 $17,190,430
Tobin C. Schilke 2020 $421,375 - $1,131,345 $1,273,662 $143,186 $11,531 $2,981,099
Tobin C. Schilke 2019 $407,126 $25,000 $86,150 $299,781 $178,123 $11,078 $1,007,258
Tobin C. Schilke 2018 $64,644 $25,000 $449,280 $1,434,350 - $233 $1,973,507
Abhay Joshi, Ph.D. 2020 $514,608 - $1,405,850 $1,913,759 $213,726 $11,731 $4,059,674
Abhay Joshi, Ph.D. 2019 $485,479 - $271,373 $939,314 $204,211 $9,520 $1,909,897
Abhay Joshi, Ph.D. 2018 $469,062 - $342,513 $1,192,465 $232,186 $9,210 $2,245,436
Dustin Sjuts 2020 $415,000 - $1,294,250 $1,306,320 $141,020 $66,242 $3,222,832
Dustin Sjuts 2019 $378,333 $50,000 $43,075 $99,927 $183,902 $45,786 $801,023
Dwight Moxie 2020 $370,104 $125,000 $1,309,383 $2,579,240 $125,426 $10,356 $4,519,508
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1479290/000147929021000089/rvncfy20proxystatementdef1.htm

What are Revance Therapeutics, Inc's Past Insider Trades?

Revance Therapeutics, Inc's most recent insider trade came on September 16, 2022 by Dwight Moxie who sold 11,000 units worth $297.8K . In the last 8 years, insiders at Revance Therapeutics, Inc have sold an estimated value of $30.1M and bought an estimated value of $8.63M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Daniel Browne, CEO and President,  Curtis Ruegg, EVP,  and Lauren Silvernail, CFO & CBO .

Revance Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1